视网膜静脉阻塞相关危险因素的研究进展
Research Advances in Risk Factors Associated with Retinal Vein Occlusion
DOI: 10.12677/acm.2025.15123693, PDF,   
作者: 罗雯伊:吉首大学医学院,湖南 吉首;于 兰*:吉首大学第四临床学院,湖南 怀化
关键词: 视网膜静脉阻塞危险因素凝血异常综述Retinal Vein Occlusion Risk Factors Thrombophilia Review
摘要: 视网膜静脉阻塞是导致视力下降的常见视网膜血管性疾病,其发病机制复杂,多种因素共同作用导致。本综述系统梳理了视网膜静脉阻塞相关的关键危险因素,研究表明在全身性血管因素中,高血压是最为确切的独立危险因素,糖尿病与高脂血症则通过加速动脉粥样硬化与内皮损伤参与致病;凝血异常因素中,以抗磷脂抗体综合征为代表的血栓前状态,通过诱发高凝状态显著增加视网膜静脉阻塞风险;在局部眼部因素中,短眼轴所致的筛板区拥挤及青光眼相关的视网膜微循环改变,共同构成静脉受压的解剖学基础。本文通过整合现有证据,旨在为视网膜静脉阻塞的个体化风险评估与一级预防策略提供理论依据,并指出未来研究应聚焦于多因素交互作用机制并为临床开展个体化防治制定了重要参考。
Abstract: Retinal vein occlusion (RVO) represents a common retinal vascular disorder that frequently leads to visual impairment, with its pathogenesis being multifactorial and complex. This review systematically delineates the key risk factors associated with RVO. Evidence demonstrates that among systemic vascular factors, hypertension stands as the most well-established independent risk factor, while diabetes mellitus and hyperlipidemia contribute to the pathogenesis through accelerated atherosclerosis and endothelial dysfunction. In the category of coagulation abnormalities, thrombophilic states, particularly antiphospholipid syndrome, significantly increase RVO risk by inducing hypercoagulability. Regarding local ocular factors, crowding at the lamina cribrosa resulting from short axial length, combined with glaucoma-associated alterations in retinal microcirculation, collectively constitute the anatomical basis for venous compression. By synthesizing current evidence, this review aims to provide a theoretical foundation for individualized risk assessment and primary prevention strategies for RVO, while proposing that future research should focus on elucidating the mechanisms underlying multifactorial interactions, thereby establishing critical references for developing personalized clinical management approaches.
文章引用:罗雯伊, 于兰. 视网膜静脉阻塞相关危险因素的研究进展[J]. 临床医学进展, 2025, 15(12): 2594-2600. https://doi.org/10.12677/acm.2025.15123693

参考文献

[1] Song, P., Xu, Y., Zha, M., Zhang, Y. and Rudan, I. (2019) Global Epidemiology of Retinal Vein Occlusion: A Systematic Review and Meta-Analysis of Prevalence, Incidence, and Risk Factors. Journal of Global Health, 9, Article ID: 010427. [Google Scholar] [CrossRef] [PubMed]
[2] Flaxel, C.J., Adelman, R.A., Bailey, S.T., Fawzi, A., Lim, J.I., Vemulakonda, G.A., et al. (2020) Retinal Vein Occlusions Preferred Practice Pattern®. Ophthalmology, 127, P288-P320. [Google Scholar] [CrossRef] [PubMed]
[3] Schmidt-Erfurth, U., Garcia-Arumi, J., Gerendas, B.S., Midena, E., Sivaprasad, S., Tadayoni, R., et al. (2019) Guidelines for the Management of Retinal Vein Occlusion by the European Society of Retina Specialists (Euretina). Ophthalmologica, 242, 123-162. [Google Scholar] [CrossRef] [PubMed]
[4] Trovato Battagliola, E., Pacella, F., Malvasi, M., Scalinci, S.Z., Turchetti, P., Pacella, E., et al. (2021) Risk Factors in Central Retinal Vein Occlusion: A Multi-Center Case-Control Study Conducted on the Italian Population: Demographic, Environmental, Systemic, and Ocular Factors That Increase the Risk for Major Thrombotic Events in the Retinal Venous System. European Journal of Ophthalmology, 32, 2801-2809. [Google Scholar] [CrossRef] [PubMed]
[5] Jefferies, P., Clemett, R. and Day, T. (1993) An Anatomical Study of Retinal Arteriovenous Crossings and Their Role in the Pathogenesis of Retinal Branch Vein Occlusions. Australian and New Zealand Journal of Ophthalmology, 21, 213-217. [Google Scholar] [CrossRef] [PubMed]
[6] Zhao, J., Sastry, S.M., Sperduto, R.D., Chew, E.Y., Remaley, N.A., Yannuzzi, L.A., et al. (1993) Arteriovenous Crossing Patterns in Branch Retinal Vein Occlusion: The Eye Disease Case-Control Study Group. Ophthalmology, 100, 423-428. [Google Scholar] [CrossRef] [PubMed]
[7] Klein, R., Klein, B.E., Moss, S.E., et al. (2000) The Epidemiology of Retinal Vein Occlusion: The Beaver Dam Eye Study. Transactions of the American Ophthalmological Society, 98, 133-141.
[8] Kim, H.R., Lee, N.K., Lee, C.S., Byeon, S.H., Kim, S.S., Lee, S.W., et al. (2023) Retinal Vascular Occlusion Risks in High Blood Pressure and the Benefits of Blood Pressure Control. American Journal of Ophthalmology, 250, 111-119. [Google Scholar] [CrossRef] [PubMed]
[9] Huang, J. (2023) Mendelian Randomization Indicates a Causal Contribution of Type 2 Diabetes to Retinal Vein Occlusion. Frontiers in Endocrinology, 14, Article ID: 1146185. [Google Scholar] [CrossRef] [PubMed]
[10] Mrugacz, M., Bryl, A. and Zorena, K. (2021) Retinal Vascular Endothelial Cell Dysfunction and Neuroretinal Degeneration in Diabetic Patients. Journal of Clinical Medicine, 10, Article No. 458. [Google Scholar] [CrossRef] [PubMed]
[11] Chang, Y., Ho, C., Chu, C., Wang, J. and Jan, R. (2021) Risk of Retinal Vein Occlusion in Patients with Diabetes Mellitus: A Retrospective Cohort Study. Diabetes Research and Clinical Practice, 171, Article ID: 108607. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, Y., Wu, S., Wen, F. and Cao, Q. (2020) Diabetes Mellitus as a Risk Factor for Retinal Vein Occlusion: A Meta-Analysis. Medicine, 99, e19319. [Google Scholar] [CrossRef] [PubMed]
[13] Ponto, K.A., Scharrer, I., Binder, H., Korb, C., Rosner, A.K., Ehlers, T.O., et al. (2019) Hypertension and Multiple Cardiovascular Risk Factors Increase the Risk for Retinal Vein Occlusions: results from the Gutenberg Retinal Vein Occlusion Study. Journal of Hypertension, 37, 1372-1383. [Google Scholar] [CrossRef] [PubMed]
[14] Stojakovic, T., Scharnagl, H., März, W., Winkelmann, B.R., Boehm, B.O. and Schmut, O. (2007) Low Density Lipoprotein Triglycerides and Lipoprotein(a) Are Risk Factors for Retinal Vascular Occlusion. Clinica Chimica Acta, 382, 77-81. [Google Scholar] [CrossRef] [PubMed]
[15] Kim, J., Lim, D.H., Han, K., Kang, S.W., Ham, D., Kim, S.J., et al. (2019) Retinal Vein Occlusion Is Associated with Low Blood High-Density Lipoprotein Cholesterol: A Nationwide Cohort Study. American Journal of Ophthalmology, 205, 35-42. [Google Scholar] [CrossRef] [PubMed]
[16] 刘明月, 陈佳玉, 常晨, 等. 炎症及动脉硬化相关因子与视网膜静脉阻塞的相关性[J]. 国际眼科杂志, 2020, 20(7): 1264-1268.
[17] Wong, T., Larsen, E., Klein, R., Mitchell, P., Couper, D., Klein, B., et al. (2005) Cardiovascular Risk Factors for Retinal Vein Occlusion and Arteriolar Embolithe Atherosclerosis Risk in Communities & Cardiovascular Health Studies. Ophthalmology, 112, 540-547. [Google Scholar] [CrossRef] [PubMed]
[18] Bakhoum, C.Y., Madala, S., Long, C.K., Adabifirouzjaei, F., Freeman, W.R., Goldbaum, M.H., et al. (2022) Retinal Vein Occlusion Is Associated with Stroke Independent of Underlying Cardiovascular Disease. Eye, 37, 764-767. [Google Scholar] [CrossRef] [PubMed]
[19] Avrutsky, M.I., Ortiz, C.C., Johnson, K.V., Potenski, A.M., Chen, C.W., Lawson, J.M., et al. (2020) Endothelial Activation of Caspase-9 Promotes Neurovascular Injury in Retinal Vein Occlusion. Nature Communications, 11, Article No. 3173. [Google Scholar] [CrossRef] [PubMed]
[20] Lampsas, S., Xenou, M., Oikonomou, E., Pantelidis, P., Lysandrou, A., Sarantos, S., et al. (2023) Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment. Molecules, 28, Article No. 969. [Google Scholar] [CrossRef] [PubMed]
[21] Kuhli‐Hattenbach, C., Miesbach, W., Lüchtenberg, M., Kohnen, T. and Hattenbach, L. (2016) Elevated Lipoprotein (a) Levels Are an Independent Risk Factor for Retinal Vein Occlusion. Acta Ophthalmologica, 95, 140-145. [Google Scholar] [CrossRef] [PubMed]
[22] Nusinovici, S., Sabanayagam, C., Teo, B.W., Tan, G.S.W. and Wong, T.Y. (2019) Vision Impairment in CKD Patients: Epidemiology, Mechanisms, Differential Diagnoses, and Prevention. American Journal of Kidney Diseases, 73, 846-857. [Google Scholar] [CrossRef] [PubMed]
[23] Chang, Y., Weng, S., Chang, C., Wang, J., Tseng, S., Wang, J., et al. (2016) Risk of Retinal Vein Occlusion Following End-Stage Renal Disease. Medicine, 95, e3474. [Google Scholar] [CrossRef] [PubMed]
[24] Fujita, A., Hashimoto, Y., Okada, A., Obata, R., Aihara, M., Matsui, H., et al. (2022) Association between Proteinuria and Retinal Vein Occlusion in Individuals with Preserved Renal Function: A Retrospective Cohort Study. Acta Ophthalmologica, 100, e1510-e7. [Google Scholar] [CrossRef] [PubMed]
[25] Tian, W., Ju, J., Guan, B., Wang, T., Zhang, J., Song, L., et al. (2025) Role of Hyperhomocysteinemia in Atherosclerosis: From Bench to Bedside. Annals of Medicine, 57, 2457527. [Google Scholar] [CrossRef] [PubMed]
[26] Bogoni, F., Brunner, M.S., Almer, G., Hörl, G., Tehlivets, Y.G., Sommer, G., et al. (2025) Homocysteine Leads to Aortic Stiffening in a Rabbit Model of Atherosclerosis. Acta Biomaterialia, 201, 412-428. [Google Scholar] [CrossRef] [PubMed]
[27] Shi, M., Zheng, J., Liu, Y., Mao, X., Wu, X., Chu, M., et al. (2024) Folate, Homocysteine, and Adverse Outcomes after Ischemic Stroke. Journal of the American Heart Association, 13, e036527. [Google Scholar] [CrossRef] [PubMed]
[28] Zhang, S., Lv, Y., Luo, X., Weng, X., Qi, J., Bai, X., et al. (2023) Homocysteine Promotes Atherosclerosis through Macrophage Pyroptosis via Endoplasmic Reticulum Stress and Calcium Disorder. Molecular Medicine, 29, Article No. 73. [Google Scholar] [CrossRef] [PubMed]
[29] Paciullo, F., Menduno, P.S., Tucci, D., Caricato, A., Cagini, C. and Gresele, P. (2022) Vitamin B12 Levels in Patients with Retinal Vein Occlusion and Their Relation with Clinical Outcome: A Retrospective Study. Internal and Emergency Medicine, 17, 1065-1071. [Google Scholar] [CrossRef] [PubMed]
[30] Garnavou-Xirou, C., Bontzos, G., Smoustopoulos, G., Velissaris, S., Papadopoulos, A., Georgopoulos, E., et al. (2024) Ocular and Genetic Risk Factors in Branch Retinal Vein Occlusion: A Comprehensive Review. MaedicaA Journal of Clinical Medicine, 19, 780-788. [Google Scholar] [CrossRef] [PubMed]
[31] McGimpsey, S.J., Woodside, J.V., Cardwell, C., Cahill, M. and Chakravarthy, U. (2009) Homocysteine, Methylenetetrahydrofolate Reductase C677T Polymorphism, and Risk of Retinal Vein Occlusion: A Meta-Analysis. Ophthalmology, 116, 1778-1787.e1. [Google Scholar] [CrossRef] [PubMed]
[32] Hernández, J.L., Sanlés, I., Pérez-Montes, R., Martínez-Taboada, V.M., Olmos, J.M., Salmón, Z., et al. (2020) Antiphospholipid Syndrome and Antiphospholipid Antibody Profile in Patients with Retinal Vein Occlusion. Thrombosis Research, 190, 63-68. [Google Scholar] [CrossRef] [PubMed]
[33] Kuhli-Hattenbach, C., Hellstern, P., Nägler, D.K., Kohnen, T. and Hattenbach, L. (2017) Prothrombin Polymorphism A19911G, Factor V HR2 Haplotype A4070G, and Plasminogen Activator-Inhibitor-1 Polymorphism 4G/5G and the Risk of Retinal Vein Occlusion. Ophthalmic Genetics, 38, 413-417. [Google Scholar] [CrossRef] [PubMed]
[34] Scharrer, I., Lüchtenberg, M., Hattenbach, L. and Kuhli-Hattenbach, C. (2010) Coagulation Disorders and the Risk of Retinal Vein Occlusion. Thrombosis and Haemostasis, 103, 299-305. [Google Scholar] [CrossRef] [PubMed]
[35] Romiti, G.F., Corica, B., Borgi, M., Visioli, G., Pacella, E., Cangemi, R., et al. (2020) Inherited and Acquired Thrombophilia in Adults with Retinal Vascular Occlusion: A Systematic Review and Meta‐Analysis. Journal of Thrombosis and Haemostasis, 18, 3249-3266. [Google Scholar] [CrossRef] [PubMed]
[36] 黄娇, 修巍威, 宋先德, 等. 系统性免疫炎症指数与视网膜分支静脉阻塞黄斑水肿风险的相关性研究[J]. 中外医药研究, 2025, 4(2): 64-66.
[37] Kazantzis, D., Machairoudia, G., Kroupis, C., Theodossiadis, G., Theodossiadis, P. and Chatziralli, I. (2022) Complete Blood Count-Derived Inflammation Indices and Retinal Vein Occlusion: A Case-Control Study. Ophthalmology and Therapy, 11, 1241-1249. [Google Scholar] [CrossRef] [PubMed]
[38] Niazi, S., Gnesin, F., Jawad, B.N., Niazi, Z., Løkkegaard, E., Mørch, L., et al. (2025) Hormonal Contraception and Retinal Vascular Occlusion Risk. American Journal of Ophthalmology, 277, 286-294. [Google Scholar] [CrossRef] [PubMed]
[39] Szigeti, A., Schneider, M., Ecsedy, M., Nagy, Z.Z. and Récsán, Z. (2015) Association between Retinal Vein Occlusion, Axial Length and Vitreous Chamber Depth Measured by Optical Low Coherence Reflectometry. BMC Ophthalmology, 15, Article No. 45. [Google Scholar] [CrossRef] [PubMed]
[40] Kim, Y.N., Shin, J.W., Park, Y.J., Lee, J.Y., Kim, J.G., Yoon, Y.H., et al. (2020) Glaucoma as a Prognostic Factor of Central Retinal Vein Occlusion: Visual and Anatomical Outcomes and Occurrence of Ischaemic Central Retinal Vein Occlusion. Acta Ophthalmologica, 99, e523-e530. [Google Scholar] [CrossRef] [PubMed]
[41] Na, K.I., Jeoung, J.W., Kim, Y.K., Lee, W.J. and Park, K.H. (2018) Incidence of Retinal Vein Occlusion in Open-Angle Glaucoma: A Nationwide, Population‐Based Study Using the Korean Health Insurance Review and Assessment Database. Clinical & Experimental Ophthalmology, 46, 637-644. [Google Scholar] [CrossRef] [PubMed]
[42] Paik, D.W., Han, K., Kang, S.W., Ham, D., Kim, S.J., Chung, T., et al. (2020) Differential Effect of Obesity on the Incidence of Retinal Vein Occlusion with and without Diabetes: A Korean Nationwide Cohort Study. Scientific Reports, 10, Article No. 10512. [Google Scholar] [CrossRef] [PubMed]
[43] Narang, S., Giran, M., Lehl, S.S., D’Cruz, S. and Sharma, A. (2021) Bilateral Combined Retinal Vascular Occlusion as a Presenting Feature in a Case of Systemic Lupus Erythematosus. Rheumatology, 60, 4949-4950. [Google Scholar] [CrossRef] [PubMed]
[44] Koliaki, C., Dalamaga, M. and Liatis, S. (2023) Update on the Obesity Epidemic: After the Sudden Rise, Is the Upward Trajectory Beginning to Flatten? Current Obesity Reports, 12, 514-527. [Google Scholar] [CrossRef] [PubMed]